Disparities Among Liver Transplant Patients
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: End Stage Liver DIsease. Basic parameters: 18 years — 65 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Individual and Structural-level Determinants Associated With Disparities Among Liver Transplant Patients
Overview
The purpose of this study is to inform healthcare interventions to reduce the disparities in liver transplant listing and in transplantation.
Detailed description
Aim 1. Establish a longitudinal cohort of patients with end-stage liver dysfunction.
Aim 2. Examine interpersonal and structural factors associated with liver transplant evaluation and listing by patient characteristics (e.g., race, ethnicity, SES, gender).
Aim 3. Examine the use of stigmatizing language among patients undergoing liver transplant based on their demographic characteristics (e.g., race, ethnicity, SES, gender).
Primary outcome measures
- Liver transplant waiting list [Time frame: Approximately one year]
- Organ transplantation [Time frame: Approximately one year]
Secondary outcome measures (3)
- Survival [Time frame: Approximately one year post-transplant, or until you are removed from the transplant list]
- Graft survival at six months [Time frame: Six months post transplant]
- Graft survival at one year [Time frame: One year post transplant]
Eligibility criteria
Inclusion criteria
\- Patients with end-stage liver, kidney, or cardiac dysfunction.
Exclusion criteria
- Patients with more than one system with end stage organ dysfunction, dementia, cognitive or sensory impairment, prior solid organ transplant.
- Patients with potential medical exclusions for transplant.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
United States · 1 center
- Mayo Clinic Arizona — Phoenix
Identifiers
NCT: NCT05981196 · 22-008581